Boothbay Fund Management, LLC Bio Xcel Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$17.7 - $33.24 $414,958 - $779,278	-23,444 Reduced 46.47%	27,006 $503,000
Q4 2022 Feb 14, 2023	BUY	$10.25 - $22.43 $517,112 - $1.13 Million	50,450 New	50,450 $1.08 Million
Q3 2021 Nov 15, 2021	SELL	$23.84 - $32.03 $171,314 - $230,167	-7,186 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.06 - $38.83 $208,825 - $279,032	7,186 New	7,186 $209,000
Q3 2020 Nov 16, 2020	SELL	$37.44 - $64.63 $1.23 Million - $2.12 Million	-32,865 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$17.62 - $58.71 $921,332 - $3.07 Million	-52,289 Reduced 61.41%	32,865 $1.74 Million
Q1 2020 May 15, 2020	BUY	$12.26 - $41.14 $722,101 - $2.42 Million	58,899 Added 224.33%	85,154 $1.9 Million
Q4 2019 Feb 14, 2020	BUY	$4.05 - $14.61 $106,332 - $383,585	26,255 New	26,255 $384,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $12.6M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.